C3i, is a full-service CDMO in Cell & Gene therapy, offering in-house services from, process development to commercial GMP manufacturing, Qc analytical development of tests and testing, biomarker development, immune monitoring, and CRO. We manufacture for Canada, US, and Europe Operating in Montreal, Canada, C3i offers an integrated structure for the development, translation and commercialisation of these ground breaking therapies. Offer our clients a "one-stop-shop" solution for the development, translation, and commercialization of their products: Our services - GMP Manufacturing Unit for Cell and Gene therapies - in-house testing Qc, Biomarker-Diagnostic and test development - Clinical Research offering KOLs, protocol development, and Key patient access - Investment & support for innovative companies
| Website | http://centrec3i.com |
| Revenue | $11.8 million |
| Employees | 97 (39 on RocketReach) |
| Founded | 2016 |
| Address | Hôpital Maisonneuve-Rosemont, Pavillon Rachel Tourigny, 5415 Boulevard de l'Assomption, Montreal, Quebec H1T 2M4, CA |
| Phone | +1 514-731-2233 |
| Technologies |
JavaScript
,
HTML
,
PHP
+13 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Cell Therapy Manufacturing, Gmp Manufacturing, Full Service Cdmo, Gene Therapy Manufacturing, Cdmo Services, Biopharmaceutical Manufacturing, Contract Manufacturing Organization, Drug Product Manufacturing, Quality Control Testing, Analytical Testing Services, Process Development, Clinical Trial Manufacturing |
| Competitors | IQVIA, PPD, Syneos Health, Parexel, Charles River Laboratories, Medpace, Covance, WCG, Celerion, ClinicalResearch.com +39 more (view full list) |
Looking for a particular C3i employee's phone or email?
The C3i annual revenue was $11.8 million in 2026.
Louisa Petropoulos is the CEO of C3i.
39 people are employed at C3i.
C3i is based in Montreal, Quebec.